LATE-BREAKING CLINICAL TRIALS | ENDOVASCULAR

Tuesday, March 10, 2026

8:00 AM - 9:15 AM EST

Location: International Ballroom Center

Moderator(s)

Behnam N. Tehrani, MD

System Associate Director for Interventional Cardiology and Executive Director of Cardiac Cath Labs
Inova Health System
Fairfax, Virginia, United States

Disclosure(s): Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ReCor: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

Mohammad M. Ansari, MD

Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States

Disclosure(s): No financial relationships to disclose
Gary M. Ansel, MD, FACC

Assistant Clinical Professor
University of Toledo
Columbus , Ohio, United States

Disclosure(s): cook Medical: Consulting Fees (e.g., advisory boards) (Ongoing), royalties (Ongoing); healthcare Inroads: Owner/Co-Owner Founder/Co-Founder (Ongoing); reflow medical: Consulting Fees (e.g., advisory boards) (Ongoing); surmodics: royalties (Ongoing)
RD

Robert Dieter, MD

Disclosure information not submitted.
Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
Three Crosses Regional Medical Center, Las Cruces, New Mexico
Monterey, California, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing); Cardiac Dimensions.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)
Ziyad Ghazzal, MD

Director, Heart, Vascular & Kidney Outpatient Center
American University of Beirut Medical Center
American University of Beirut
Riad El Solh, Beyrouth, Lebanon

Disclosure(s): No financial relationships to disclose
AN

Aravinda Nanjundappa, MD, FSCAI

Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States

Disclosure(s): No financial relationships to disclose
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)
Olga Toleva, MD, MPH

Lead of Advanced Coronary Physiology Program
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure(s): Philips; Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Behnam N. Tehrani, MD: Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ReCor: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Mohammad M. Ansari, MD: No financial relationships to disclose

Gary M. Ansel, MD, FACC: cook Medical: Consulting Fees (e.g., advisory boards) (Ongoing), royalties (Ongoing); healthcare Inroads: Owner/Co-Owner Founder/Co-Founder (Ongoing); reflow medical: Consulting Fees (e.g., advisory boards) (Ongoing); surmodics: royalties (Ongoing)

Steven L. Goldberg, MD, FSCAI, FACC: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing); Cardiac Dimensions.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Ziyad Ghazzal, MD: No financial relationships to disclose

Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)

Olga Toleva, MD, MPH: Philips; Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)